Someone with a lot of money to spend has taken a bullish stance on Ascendis Pharma ASND.
And retail traders should know.
We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.
Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with ASND, it often means somebody knows something is about to happen.
So how do we know what this whale just did?
Today, Benzinga's options scanner spotted 20 uncommon options trades for Ascendis Pharma.
This isn't normal.
The overall sentiment of these big-money traders is split between 75% bullish and 25%, bearish.
Out of all of the special options we uncovered, 2 are puts, for a total amount of $300,000, and 18 are calls, for a total amount of $2,185,824.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $70.0 to $80.0 for Ascendis Pharma over the last 3 months.
Volume & Open Interest Development
In terms of liquidity and interest, the mean open interest for Ascendis Pharma options trades today is 1208.25 with a total volume of 5,113.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Ascendis Pharma's big money trades within a strike price range of $70.0 to $80.0 over the last 30 days.
Ascendis Pharma Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
---|---|---|---|---|---|---|---|---|
ASND | CALL | TRADE | BULLISH | 07/21/23 | $80.00 | $890.0K | 1.2K | 555 |
ASND | CALL | SWEEP | BULLISH | 05/19/23 | $80.00 | $202.5K | 1.5K | 358 |
ASND | CALL | SWEEP | BULLISH | 07/21/23 | $80.00 | $183.0K | 1.2K | 371 |
ASND | PUT | TRADE | BULLISH | 06/16/23 | $80.00 | $170.0K | 1.0K | 1.0K |
ASND | CALL | SWEEP | BEARISH | 07/21/23 | $80.00 | $162.6K | 1.2K | 89 |
Where Is Ascendis Pharma Standing Right Now?
- With a volume of 500,319, the price of ASND is up 1.02% at $94.97.
- RSI indicators hint that the underlying stock may be overbought.
- Next earnings are expected to be released in 96 days.
What The Experts Say On Ascendis Pharma:
- Morgan Stanley has decided to maintain their Equal-Weight rating on Ascendis Pharma, which currently sits at a price target of $109.
- Cantor Fitzgerald has decided to maintain their Overweight rating on Ascendis Pharma, which currently sits at a price target of $152.
- Credit Suisse has decided to maintain their Neutral rating on Ascendis Pharma, which currently sits at a price target of $89.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Ascendis Pharma, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.